Your browser doesn't support javascript.
loading
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril, Vera; Druzdz, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J.
Afiliação
  • Bril V; University Health Network, Toronto, ON, Canada. Electronic address: vera.bril@utoronto.ca.
  • Druzdz A; Department of Neurology, Municipal Hospital, Poznan, Poland.
  • Grosskreutz J; Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany.
  • Habib AA; MDA ALS and Neuromuscular Center, University of California, Irvine, CA, USA.
  • Mantegazza R; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.
  • Sacconi S; Université Côte d'Azur, Peripheral Nervous System and Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Utsugisawa K; Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
  • Vissing J; Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Vu T; Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Boehnlein M; UCB Pharma, Monheim, Germany.
  • Bozorg A; UCB Pharma, Morrisville, NC, USA.
  • Gayfieva M; UCB Pharma, Slough, UK.
  • Greve B; UCB Pharma, Monheim, Germany.
  • Woltering F; UCB Pharma, Monheim, Germany.
  • Kaminski HJ; George Washington University, Washington, DC, USA.
Lancet Neurol ; 22(5): 383-394, 2023 05.
Article em En | MEDLINE | ID: mdl-37059507

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Miastenia Gravis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans / Newborn Idioma: En Revista: Lancet Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Miastenia Gravis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans / Newborn Idioma: En Revista: Lancet Neurol Ano de publicação: 2023 Tipo de documento: Article